Ultrasound Guided Nerve Block for Hip Fracture Pain Management at Emergency Department
1 other identifier
interventional
72
0 countries
N/A
Brief Summary
The main objective is to determine if ultrasound guided suprainguinal iliac fascia block leads in better clinical outcomes such as pain management or time to home discharge.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2022
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 25, 2022
CompletedStudy Start
First participant enrolled
June 1, 2022
CompletedFirst Posted
Study publicly available on registry
June 3, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2023
CompletedJune 3, 2022
June 1, 2022
6 months
February 25, 2022
June 1, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain Control after Ultrasound guided nerve block vs iv painkillers
Using Visual Analogue Scale (1-No pain; 10 -worst pain) measure difference between pain during arrival at Emergency Department and 30 minutes after Ultrasound guided nerve block vs iv painkillers
During Emergency Department stay (up to 12 hours)
Secondary Outcomes (4)
Patient Hip Mobility with tolerable pain
Immediately Before Discharging home assessed up to 2 weeks.
Functionality: Sit to Stand Test
Immediately Before Discharging home assessed up to 2 weeks.
Opioid Use
Immediately Before Discharging home assessed up to 2 weeks.
Patient Satisfaction
Immediately Before Discharging home assessed up to 2 weeks.
Study Arms (2)
No Nerve Blocking
NO INTERVENTIONPain management at ER Department will be as usually with iv drugs and 3 kilogram soft traction.
Ultrasound Nerve blocking
ACTIVE COMPARATORPain management at ER Department will be as usually with iv drugs and ultrasound guided Suprainguinal Iliac Fascia Nerve Block.
Interventions
Pain management at ER Department will be as usually with iv drugs and ultrasound guided Suprainguinal Iliac Fascia Nerve Block.
Eligibility Criteria
You may qualify if:
- Low energy Hip Fracture
You may not qualify if:
- Present any other synchronic fracture.
- Drug allergy for drugs used for nerve blocking
- Skin infection at injection site.
- Contraindication due to comorbidities.
- Pathologic fractures.
- Cognitive impairment
- Do not give his consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Borja Alcobía-Díaz, MD, PhD
Clinical Assistant
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD, Principal Investigator
Study Record Dates
First Submitted
February 25, 2022
First Posted
June 3, 2022
Study Start
June 1, 2022
Primary Completion
December 1, 2022
Study Completion
February 1, 2023
Last Updated
June 3, 2022
Record last verified: 2022-06
Data Sharing
- IPD Sharing
- Will not share
Email Contact